Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 44348301000001119 | Sodium cromoglicate + Xylometazoline (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 44348401000001110 | Sodium cromoglicate + Xylometazoline | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium cromoglicate + Xylometazoline | Is a | Product containing cromolyn sodium | false | Inferred relationship | Existential restriction modifier | ||
| Sodium cromoglicate + Xylometazoline | Is a | Product containing xylometazoline | false | Inferred relationship | Existential restriction modifier | ||
| Sodium cromoglicate + Xylometazoline | Has active ingredient | Cromoglicate sodium | true | Inferred relationship | Existential restriction modifier | ||
| Sodium cromoglicate + Xylometazoline | Has active ingredient | Xylometazoline | true | Inferred relationship | Existential restriction modifier | ||
| Sodium cromoglicate + Xylometazoline | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Is a | True | Sodium cromoglicate + Xylometazoline | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR